Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Lotus Pharmaceutical becomes strategic partner for the commercialization of Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region
Thursday, February 06, 2025Klinge Biopharma GmbH the exclusive owner of the global commercialization rights of FYBAHZANTIVE aflibercept Formycons biosimilar to Eylea informed Formycon AG that it has concluded an exclusive license agreement with Lotus Pharmaceutical Lotus a mul...
Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment
Thursday, February 06, 2025Argent BioPharmaa clinicalstage biopharmaceutical company brings hope to epilepsy patients For thousands of patients with refractory epilepsycommonly referred to as drugresistant epilepsythe search for effective treatment often feels like navigating...
Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem
Thursday, February 06, 2025Actinogen Medical Limitedannounces that the World Health Organization WHO has granted the nonproprietary name of emestedastat to Actinogen for its XanamemUE onceaday small molecule in accordance with the WHOs Procedure for the Selection of Recommende...
Africa and Europe Join Forces to Revolutionize RNA-based Vaccines and Therapeutics Production: MoU Signed Between EVA Pharma, DNA Script, Quantoom Biosciences
Thursday, February 06, 2025Africas EVA Pharma Frances DNA Script and Belgiums Quantoom Biosciences have signed a Memorandum of Understanding today on the sidelines of the nd Vaccine and Other Health Products Manufacturing Forum for African Union Member States
Hyundai Bio (HDB) and DNDi Sign MOU for Joint Development of Xafty-Based Dengue Treatment
Wednesday, February 05, 2025Hyundai Bioscienceand the Drugs for Neglected Diseases initiative DNDi an international nonprofit organization that discovers develops and delivers treatments for neglected patients jointly announced today the signing of a Memorandum of Understanding...
China Medical University and Healthcare System Pioneers AI-Driven Drug Discovery and Allogeneic CAR-T Therapy: A Groundbreaking Leap in Cancer Treatment
Wednesday, February 05, 2025Healthcare Expo Taiwan is a professionaloriented exposition involving healthcare informationcommunication technology biopharmaceutical and medical device industries Attended by healthcare professionals from all over the world
TriLink BioTechnologies® and Aldveron enter into non-exclusive license and supply agreement for CleanCap® mRNA capping technology
Wednesday, February 05, 2025TriLink BioTechnologies TriLink a Maravai LifeSciences companyand global provider of life science reagents and services has signed a nonexclusive License and Supply Agreement with Aldevron a leading global Contract Development
Eleva and 3PBIOVIAN sign strategic GMP manufacturing and technology alliance to boost capacity for Eleva’s platform and pipeline
Wednesday, February 05, 2025Eleva a pioneer in unlocking difficulttoproduce biologics based on a breakthrough manufacturing platform and PBIOVIAN a leading contract development and manufacturing organization CDMO announced today a strategic alliance to collaborate on the manufa...
D&D Pharmatech Completes Patient Enrollment for 48-Week Phase 2 Trial of DD01 in MASH Treatment
Tuesday, February 04, 2025DD Pharmatech Inc a clinicalstage biotechnology company focused on the development of diseasemodifying drugs today announced that patient enrollment has been completed for DDDN an ongoing Phase trial designed to evaluate the efficacy and safety of D...
RSV human challenge trial contract signed with new client, Inhalon Biopharma
Tuesday, February 04, 2025HVIVO plc a fastgrowing specialist contract research organisation CRO and world leader in testing infectious and respiratory disease products using human challenge clinical trials announces that it has signed a contract with Inhalon Biopharma Inc Inh...
